首页> 外文期刊>BioMed research international >Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy
【24h】

Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy

机译:ABC转运蛋白在顽固性癫痫耐药机制中的作用研究进展

获取原文
获取原文并翻译 | 示例
           

摘要

The pathogenesis of intractable epilepsy is not fully clear. In recent years, both animal and clinical trials have shown that the expression of ATP-binding cassette (ABC) transporters is increased in patients with intractable epilepsy; additionally, epileptic seizures can lead to an increase in the number of sites that express ABC transporters. These findings suggest that ABC transporters play an important role in the drug resistance mechanism of epilepsy. ABC transporters can perform the funcions of a drug efflux pump, which can reduce the effective drug concentration at epilepsy lesions by reducing the permeability of the blood brain barrier to antiepileptic drugs, thus causing resistance to antiepileptic drugs. Given the important role of ABC transporters in refractory epilepsy drug resistance, antiepileptic drugs that are not substrates of ABC transporters were used to obtain ABC transporter inhibitors with strong specificity, high safety, and few side effects, making them suitable for long-term use; therefore, these drugs can be used for future clinical treatment of intractable epilepsy.
机译:顽固性癫痫的发病机制并不完全清楚。近年来,动物和临床试验都表明,在顽固的癫痫患者中,ATP结合盒(ABC)转运蛋白的表达增加;另外,癫痫发作可以导致表达ABC转运蛋白的部位数量增加。这些研究结果表明,ABC运输器在癫痫的耐药机制中发挥着重要作用。 ABC转运蛋白可以通过降低血脑屏屏障对抗癫痫药物的渗透性来降低癫痫病变的有效药物浓度,从而导致抗癫痫药物的渗透性,从而导致对抗癫痫药物的耐药性。鉴于ABC转运蛋白在难治性癫痫耐药性中的重要作用,使用ABC转运蛋白基材的抗癫痫药物用于获得具有强大特异性,高安全性和副作用的ABC转运蛋白抑制剂,使其适合长期使用;因此,这些药物可用于未来顽固性癫痫的临床治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号